GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of compounding is the most under-discussed thing in c/hplc — 18 comments in the full submission. View in context.
309
c/compounding·submitted 1 year ago by u/mikkel_correia

compounding is the most under-discussed thing in c/hplc

Questionbranch of 5 comments

Week 76 update. 22kg down from the start, muscle cramps basically gone since about week 33. Things that worked: consistency, protein at breakfast, walking more than I want to. Things that did not: everything I bought on the internet to help with muscle cramps. The part that surprised me is how much of this is admin.…

Read the full submission and all 18 comments →

This branch

5 comments, started 1 year ago
u/prior_auth_painMOD19 points·1 year ago

Tracking number removed. It identifies both ends of a shipment.

replysharereportpermalink
u/lipid_panel_larrybloodwork8 points·1 year ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink
u/discount_math_dm5 points·1 year ago

the shortage list is temporary, it ends and compounding becomes illegal again

replysharereportpermalink
u/niels_roos2 points·1 year ago

the shortage list is temporary, it ends and compounding becomes illegal again

Yes, exactly this, and it is the bit that took me 36 weeks to accept.

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.